giant
panda
ailuropoda
melanoleuca
endem
china
list
intern
union
conserv
natur
iucn
endang
conserv
intern
traffic
endang
speci
cite
appendix
class
protect
statu
china
popul
wild
estim
individu
captiv
popul
wei
et
al
past
decad
much
consider
focus
nutrit
reproduct
captiv
giant
panda
prevent
control
infecti
diseas
ignor
impact
infecti
diseas
wildlif
popul
document
varieti
wildlif
speci
highlight
need
consid
infecti
diseas
conserv
plan
dobson
foufopoulo
captiv
giant
panda
china
kept
zoo
breed
center
anim
red
panda
also
kept
visitor
contact
giant
panda
close
take
photo
even
feed
anim
although
forbidden
circumst
avoid
pathogen
could
transmit
among
speci
individu
includ
giant
panda
visitor
also
transmit
pathogen
anim
although
dog
cat
allow
enter
place
giant
panda
live
breeder
visitor
pet
probabl
transmit
pathogen
panda
veterinari
microbiolog
serum
sampl
giant
panda
three
captiv
facil
test
antibodi
five
virus
carnivor
antibodi
titer
canin
distemp
viru
cdv
two
facil
giant
panda
vaccin
variabl
canin
adenoviru
canin
parvoviru
cpv
titer
vaccin
group
posit
titer
high
vari
among
individu
except
one
vaccin
panda
extrem
high
titer
indic
infect
field
viru
follow
vaccin
result
suggest
vaccin
use
giant
panda
elicit
consist
antibodi
titer
antibodi
titer
cdv
cpv
unvaccin
giant
panda
highli
variabl
especi
cpv
titer
almost
half
sera
cpv
antibodi
posit
cpv
titer
high
enough
suggest
infect
viru
canin
coronaviru
ccv
canin
parainfluenza
viru
cpiv
titer
detect
serum
sampl
result
studi
emphas
need
research
infecti
diseas
giant
panda
develop
suitabl
vaccin
speci
elsevi
bv
right
reserv
report
canin
distemp
viru
cdv
canin
parvoviru
cpv
canin
coronaviru
ccv
implic
diseas
mortal
giant
panda
qiu
mainka
mainka
et
al
qiao
et
al
instanc
three
panda
infect
cdv
two
die
chongq
zoo
two
panda
die
cdv
nanj
zoo
hu
et
al
huang
giant
panda
cpv
infect
show
diarrhea
vomit
waterlik
fece
wu
et
al
ccv
caus
acut
enter
panda
fuzhou
zoo
cdv
ccv
strain
also
isol
giant
panda
li
et
al
hu
et
al
mainka
et
al
assay
antibodi
titer
cdv
ccv
canin
herpesviru
chv
pseudorabi
viru
prv
canin
adenoviru
type
cpv
sera
eight
unvaccin
panda
detect
antibodi
cdv
ccv
cpv
loeffler
et
al
janssen
et
al
vaccin
cub
modifi
live
cdv
vaccin
may
contribut
gastrointestin
respiratori
ill
dental
abnorm
enamel
eros
found
giant
panda
may
relat
earli
infect
cdv
bittegeko
et
al
janssen
et
al
object
studi
investig
exposur
giant
panda
chines
captiv
facil
common
infecti
virus
carnivor
compar
differ
antibodi
titer
vaccin
unvaccin
giant
panda
evalu
antibodi
respons
local
produc
vaccin
serum
sampl
obtain
male
femal
unknown
gender
giant
panda
individu
three
captiv
facil
china
sixtyseven
sampl
wl
cpb
five
bjz
tabl
blood
sampl
collect
panda
anesthet
semen
collect
artifici
insemin
routin
physic
examin
februari
june
cpb
bjz
vaccin
panda
month
prior
blood
sampl
collect
panda
anesthet
ketamin
hydrochlorid
mgkg
bodi
weight
first
pharmaci
co
shanghai
china
staff
veterinarian
cpb
vaccin
giant
panda
chines
manufactur
multival
vaccin
cdv
cpv
ccv
canin
parainfluenza
viru
cpiv
rabi
viru
dog
rabi
compon
vaccin
modifi
live
virus
rabi
viru
kill
formalin
bjz
vaccin
inactiv
cdv
vaccin
strain
dose
concentr
viru
vaccin
unknown
least
unobtain
one
giant
panda
call
dadi
born
wl
transfer
bjz
octob
vaccin
inact
cdv
vaccin
collect
serum
sampl
dadi
wl
april
bjz
march
serum
sampl
store
analysi
serum
sampl
assay
presenc
antibodi
cdv
ccv
viru
neutral
appel
robson
kimber
et
al
indic
cell
assay
vero
madindarbi
canin
kidney
mdck
cell
respect
cell
line
obtain
china
institut
veterinari
drug
control
serum
dilut
began
report
last
dilut
cytopath
effect
observ
indic
cell
antibodi
titer
cpiv
measur
hemagglutin
inhibit
use
porcin
red
blood
cell
chicken
red
blood
cell
respect
start
serum
dilut
hemagglutin
inhibit
assay
perform
accord
method
describ
carmichael
et
al
result
report
highest
dilut
hemagglutin
observ
antigen
use
assay
viru
strain
isol
dog
veterinari
research
institut
academi
militari
medic
scienc
posit
control
sera
dog
confirm
infect
virus
statist
analysi
perform
spss
version
softwar
spss
inc
chicago
il
usa
mannwhitney
test
use
compar
antibodi
titer
vaccin
unvaccin
anim
cdv
cpv
variat
cdv
cpv
vaccin
titer
age
sex
assess
kruskalw
mannwhitney
test
respect
ninetytwo
serum
sampl
giant
panda
three
captiv
facil
test
antibodi
cdv
ccv
cpiv
tabl
studi
antibodi
titer
classifi
neg
neg
lowest
test
dilut
suspect
low
posit
posit
titer
cdv
cpv
classifi
suspect
posit
titer
categor
cdv
cpv
vaccin
titer
cdv
cpv
vari
neg
high
posit
tabl
fig
titer
cdv
rang
neg
suspect
posit
tabl
fig
two
cpv
titer
suspect
categori
posit
titer
posit
categori
rang
tabl
fig
panda
vaccin
show
posit
titer
one
vaccin
anim
extrem
high
suggest
exposur
field
strain
viru
tabl
fig
titer
cdv
unvaccin
giant
panda
wl
rang
neg
suspect
posit
tabl
fig
unvaccin
panda
sampl
show
posit
antibodi
titer
cdv
nearli
half
cpv
titer
wl
posit
titer
tabl
fig
dadi
transfer
wl
bjz
cpv
titer
anim
rose
april
march
titer
cpv
increas
fourfold
suggest
individu
expos
cpv
sinc
arriv
bjz
cpv
titer
studi
vari
age
sex
p
respect
sampl
period
antibodi
half
unvaccin
panda
titer
fell
suspect
categori
six
posit
highest
titer
tabl
fig
antibodi
titer
cdv
p
p
higher
vaccin
group
unvaccin
group
signific
differ
antibodi
titer
cpv
p
vaccin
unvaccin
group
antibodi
titer
ccv
cpiv
neg
unvaccin
vaccin
group
studi
examin
exposur
preval
select
canin
virus
vaccin
unvaccin
giant
panda
compar
antibodi
titer
two
group
result
indic
giant
panda
may
respond
exposur
field
strain
cdv
cpv
vaccin
use
studi
site
pathogen
may
question
valu
known
level
antibodi
titer
pathogen
signific
giant
panda
level
protect
conserv
approach
interpret
data
consid
low
posit
titer
suspect
low
posit
titer
may
suggest
nonspecif
inhibit
assay
wane
titer
exposur
viru
vaccin
earli
stage
seroconvers
crossreact
relat
viru
cdv
highli
contagi
morbilliviru
caus
multisystem
diseas
varieti
domest
wild
carnivor
deem
et
al
believ
giant
panda
suscept
cdv
mortal
may
high
zoo
china
li
et
al
hu
et
al
studi
unvaccin
giant
panda
antibodi
cdv
one
explan
may
surviv
rate
infect
anim
low
expos
anim
exist
sampl
popul
cdv
one
import
element
caus
diarrhea
giant
panda
neonat
cub
prone
diarrha
common
captiv
giant
panda
associ
high
mortal
loeffler
et
al
anoth
possibl
explan
might
field
viru
elicit
strong
immun
respons
even
though
kill
infect
anim
third
possibl
simpli
expos
viru
much
preval
antibodi
titer
cpv
much
higher
cdv
unvaccin
panda
studi
nearli
half
unvaccin
anim
demonstr
titer
cpv
consist
find
mainka
et
al
detect
antibodi
cpv
giant
panda
interestingli
preval
posit
titer
cpv
similar
studi
captiv
red
panda
china
qin
et
al
infecti
hepat
caus
found
canid
bear
skunk
william
barker
six
unvaccin
panda
demonstr
titer
highest
titer
suggest
panda
studi
expos
et
al
also
detect
antibodi
titer
unvaccin
giant
panda
posit
rate
high
titer
rang
studi
vaccin
titer
cdv
cpv
vari
neg
highli
posit
titer
cdv
rang
neg
suspect
posit
dadi
produc
high
posit
antibodi
titer
vaccin
suggest
vaccin
use
anim
elicit
consist
antibodi
titer
wang
et
al
survey
antibodi
canin
distemp
attenu
live
vaccin
giant
panda
found
attenu
vaccin
inadequ
stimul
giant
panda
produc
high
level
antibodi
cdv
base
observ
wide
understood
risk
use
vaccin
untest
exot
speci
suggest
modifiedl
kill
canin
vaccin
appropri
use
giant
panda
vaccin
giant
panda
carri
high
preval
posit
cpv
titer
consist
find
loeffler
et
al
demonstr
giant
panda
vaccin
canin
vaccin
posit
cpv
titer
studi
show
high
degre
variat
cpv
titer
vaccin
giant
panda
clearli
magnitud
distribut
valu
cpv
vaccin
giant
panda
studi
meet
expect
effect
vaccin
titer
vaccin
panda
highli
variabl
among
individu
although
titer
fell
posit
rang
loeffler
et
al
detect
antibodi
vaccin
individu
differ
result
clear
whether
posit
titer
vaccin
group
induc
vaccin
natur
exposur
titer
one
vaccin
individu
extrem
high
suggest
exposur
field
strain
viru
panda
report
shown
sign
ill
recent
similar
variabl
antibodi
titer
vaccin
found
anoth
studi
captiv
red
panda
giant
panda
cpb
qin
et
al
loeffler
et
al
giant
red
panda
cpb
vaccin
attenu
vaccin
dog
data
effect
safeti
vaccin
wildlif
well
vaccin
produc
highli
variabl
titer
two
speci
high
variabl
vaccin
respons
among
individu
suggest
qualiti
vaccin
may
inconsist
altern
explan
viabl
vaccin
titer
includ
inconsist
deliveri
vaccin
variabl
respons
giant
panda
individu
antigen
china
trial
conduct
evalu
effect
safeti
vaccin
wildlif
experi
dog
view
potenti
risk
attenu
live
vaccin
giant
panda
necessari
assay
effect
safeti
vaccin
prior
use
vaccin
titer
studi
vari
age
sex
possibl
may
vari
number
success
year
anim
vaccin
serial
sampl
past
medic
record
avail
necessari
analysi
ccv
caus
enter
canid
mainka
et
al
qiao
et
al
detect
antibodi
ccv
giant
panda
hu
et
al
isol
ccv
strain
one
giant
panda
howev
detect
ccv
cpiv
antibodi
unvaccin
vaccin
group
studi
suggest
ccv
cpiv
infect
preval
studi
popul
assay
sensit
panda
sera
anoth
explan
viru
strain
prepar
vaccin
appropri
immun
panda
conclus
result
suggest
exposur
captiv
giant
panda
facil
cdv
cpv
cav
may
concern
vaccin
present
use
may
dubiou
efficaci
safeti
result
studi
reemphas
need
research
regard
preval
risk
signific
carnivor
infecti
diseas
captiv
giant
panda
china
furthermor
emphas
need
develop
new
vaccin
protect
giant
panda
infecti
diseas
